In This Section:
Obesity
Obesity
The high prevalence and increasing incidence of obesity and associated cardiovascular risk emphasises the need to focus on obesity reduction in this high-risk population.
Metabolic syndrome (MetS) is the coexistence of obesity-related cardiovascular risk factors including hypertension, diabetes and dyslipidaemia. MetS is a precursor for atherosclerosis, including premature coronary artery disease, and cardiovascular mortality.
This educational hub has been supported by Boehringer Ingelheim. Boehringer Ingelheim has had no influence over the content. This educational hub is not intended for UK or IRELAND based physicians.
Close X
Other videos you might like
Video
ECO 23: Impact of Obesity on Heart Failure Outcomes
Watch time: 7m 7s
Video Series
e-SPACE Cardio-Renal-Metabolic 2023
Watch time: 16h 19m 46s (19 videos)
Video
Obesity Management Strategies in 2023
Watch time: 17m 7s
Video Series
Dysphagia and the Management of Patients in Need of Lipid-Lowering
Watch time: 1h 7m 2s (4 videos)
Video
SPLENDOR: Metabolic Surgery and Risk of MACE in NASH
Watch time: 5m 41s
Recent Videos
Video
ECO 23: Impact of Obesity on Heart Failure Outcomes
Watch time: 7m 7s
Video Series
e-SPACE Cardio-Renal-Metabolic 2023
Watch time: 16h 19m 46s (19 videos)
Video
Obesity Management Strategies in 2023
Watch time: 17m 7s
Video
EASD 22: SURMOUNT-MMO: Tirzepatide in Obese Type II Diabetes Patients
Watch time: 7m 48s
Video Series
Dysphagia and the Management of Patients in Need of Lipid-Lowering
Watch time: 1h 7m 2s (4 videos)
Video
SPLENDOR: Metabolic Surgery and Risk of MACE in NASH
Watch time: 5m 41s